These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15069775)

  • 1. Surrogate markers in oncology practice and anticancer drug development: lessons learned from antiretroviral therapy?
    Remick SC
    Cancer Invest; 2004; 22(1):164-8. PubMed ID: 15069775
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of surrogate markers in the clinical development of antiretroviral therapy: a model for early evaluation of targeted cancer drugs.
    Petrella M; Montaner J; Batist G; Wainberg MA
    Cancer Invest; 2004; 22(1):149-60. PubMed ID: 15069773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacogenomics of antiretroviral and cytotoxic treatments.
    Stebbing J; Bower M
    Lancet Oncol; 2006 Jan; 7(1):61-8. PubMed ID: 16389185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumour effects of antiretroviral therapy.
    Monini P; Sgadari C; Toschi E; Barillari G; Ensoli B
    Nat Rev Cancer; 2004 Nov; 4(11):861-75. PubMed ID: 15516959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical development of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors: what lessons have we learned?
    Hidalgo M
    Adv Exp Med Biol; 2008; 610():128-43. PubMed ID: 18593020
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV clinical trial design for antiretroviral development: moving forward.
    Chan-Tack KM; Struble KA; Morgensztejn N; Murray JS; Gulick R; Cheng B; Weller I; Miller V
    AIDS; 2008 Nov; 22(18):2419-27. PubMed ID: 19005265
    [No Abstract]   [Full Text] [Related]  

  • 7. The future of oncology therapeutics.
    Mansinho A; Boni V; de Miguel M; Calvo E
    Expert Rev Anticancer Ther; 2017 Jul; 17(7):563-565. PubMed ID: 28504011
    [No Abstract]   [Full Text] [Related]  

  • 8. HIV-Associated Anal Dysplasia and Anal Carcinoma.
    Oette M; Mosthaf FA; Sautter-Bihl ML; Esser S
    Oncol Res Treat; 2017; 40(3):100-105. PubMed ID: 28253522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modern anti-cancer therapy: current state and future developments].
    Bokemeyer C; Hiddemann W
    Dtsch Med Wochenschr; 2014 Oct; 139(41):2067. PubMed ID: 25268204
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular imaging: what picture does it paint for future oncology?
    Price P; Jones T
    Drug Discov Today; 2002 Jul; 7(14):741-3. PubMed ID: 12547021
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiretroviral Therapy.
    Brock JB; Henderson H
    J Miss State Med Assoc; 2015 Jun; 56(6):166, 171-2. PubMed ID: 26242056
    [No Abstract]   [Full Text] [Related]  

  • 12. HIV-Associated Gastrointestinal Cancer.
    Jensen BE; Oette M; Haes J; Häussinger D
    Oncol Res Treat; 2017; 40(3):115-118. PubMed ID: 28253521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers in oncology drug development: rescuers or troublemakers?
    Marrer E; Dieterle F
    Expert Opin Drug Metab Toxicol; 2008 Nov; 4(11):1391-402. PubMed ID: 18950281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of unbound drug in pharmacokinetics/pharmacodynamics and in therapy.
    Calvo R; Lukas JC; Rodriguez M; Leal N; Suarez E
    Curr Pharm Des; 2006; 12(8):977-87. PubMed ID: 16533165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer therapeutics: personal experiences and future perspectives.
    Mihich E
    Cancer Biol Ther; 2004 Sep; 3(9):911-5. PubMed ID: 15326391
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent advances in medical oncology--1995-1996.
    Sikov WM
    Med Health R I; 1996 Mar; 79(3):92-9. PubMed ID: 8901289
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV-Associated Urogenital Malignancies.
    Hentrich M; Pfister D
    Oncol Res Treat; 2017; 40(3):106-112. PubMed ID: 28253510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent updates for designing CCR5 antagonists as anti-retroviral agents.
    Shah HR; Savjani JK
    Eur J Med Chem; 2018 Mar; 147():115-129. PubMed ID: 29425816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale for biomarkers and surrogate end points in mechanism-driven oncology drug development.
    Park JW; Kerbel RS; Kelloff GJ; Barrett JC; Chabner BA; Parkinson DR; Peck J; Ruddon RW; Sigman CC; Slamon DJ
    Clin Cancer Res; 2004 Jun; 10(11):3885-96. PubMed ID: 15173098
    [No Abstract]   [Full Text] [Related]  

  • 20. Anticancer drug discovery and development.
    Colotta F
    Adv Exp Med Biol; 2008; 610():19-42. PubMed ID: 18593013
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.